Insider · CIK 0002028474
Framework Ventures IV L.P.
Files at SDEV (NovaBay Pharmaceuticals, Inc.), BETR (Better Home & Finance Holding Co). First filing Mar 11, 2026, latest Mar 23, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BETR: Better Home & Finance Holding Co
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Better Home & Finance Holding Co | $1.2M 40,000 shares | +4% | +188% from low-66% from high | |
| 56Moderate | Better Home & Finance Holding Co | $1.5M 53,000 shares | +6% | +188% from low-66% from high | |
| 49Moderate | Better Home & Finance Holding Co | $739k 25,000 shares | +3% | +185% from low-67% from high | |
| 53Moderate | Better Home & Finance Holding Co | $1.0M 29,494 shares | +4% | +242% from low-60% from high | |
| 51Moderate | Better Home & Finance Holding Co | $1.2M 31,598 shares | +6% | +286% from low-59% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | BETR Better Home & Finance Holding Co | POpen-market purchase Common Stockindirect: See Footnote | +40,000 | $29.60 | $1.2M | 952,312 | Mar 23, 2026 |
| Mar 19, 2026 | BETR Better Home & Finance Holding Co | POpen-market purchase Common Stockindirect: See Footnote | +53,000 | $28.48 | $1.5M | 912,312 | Mar 19, 2026 |
| Mar 16, 2026 | BETR Better Home & Finance Holding Co | POpen-market purchase Common Stockindirect: See Footnote | +25,000 | $29.55 | $739k | 859,312 | Mar 16, 2026 |
| Mar 13, 2026 | BETR Better Home & Finance Holding Co | POpen-market purchase Common Stockindirect: See Footnote | +29,494 | $34.12 | $1.0M | 834,312 | Mar 13, 2026 |
| Mar 9, 2026 | BETR Better Home & Finance Holding Co | POpen-market purchase Common Stockindirect: See Footnote | +10,000 | $35.46 | $355k | 571,908 | Mar 11, 2026 |
| Mar 10, 2026 | BETR Better Home & Finance Holding Co | XIn-the-money exercise Common Stockindirect: See Footnote | +105,656 | $27.00 | $2.9M | 677,564 | Mar 11, 2026 |
| Mar 10, 2026 | BETR Better Home & Finance Holding Co | XIn-the-money exercise Common Stockindirect: See Footnote | +105,656 | $27.25 | $2.9M | 783,220 | Mar 11, 2026 |
| Mar 11, 2026 | BETR Better Home & Finance Holding Co | POpen-market purchase Common Stockindirect: See Footnote | +21,598 | $39.73 | $858k | 804,818 | Mar 11, 2026 |
| Mar 10, 2026 | BETR Better Home & Finance Holding Co | XIn-the-money exercise Warrants (right to buy)derivativeindirect: See Footnote | -105,656 | $0.00 | $0 | 105,656 | Mar 11, 2026 |
| Mar 10, 2026 | BETR Better Home & Finance Holding Co | XIn-the-money exercise Warrants (right to buy)derivativeindirect: See Footnote | -105,656 | $0.00 | $0 | 0 | Mar 11, 2026 |
| Oct 21, 2025 | SDEV NovaBay Pharmaceuticals, Inc. | CConversion Common Stock | +56,806,080 | $0.00 | $0 | 56,806,080 | Nov 3, 2025 |
| Oct 16, 2025 | SDEV NovaBay Pharmaceuticals, Inc. | POpen-market purchase Pre-Funded Warrants (Right to Buy)derivative | +2,702,703 | $0.00 | $0 | 2,702,703 | Nov 3, 2025 |
| Oct 16, 2025 | SDEV NovaBay Pharmaceuticals, Inc. | JOther Series D Non-Voting Convertible Preferred Stockderivative | +220,663 | $0.00 | $0 | 220,663 | Oct 22, 2025 |
| Oct 16, 2025 | SDEV NovaBay Pharmaceuticals, Inc. | JOther Series E Non-Voting Convertible Preferred Stockderivative | +134,375 | $0.00 | $0 | 134,375 | Oct 22, 2025 |
| Oct 16, 2025 | SDEV NovaBay Pharmaceuticals, Inc. | JOther Series D Non-Voting Convertible Preferred Stockderivative | +220,663 | $0.00 | $0 | 220,663 | Oct 20, 2025 |
| Oct 16, 2025 | SDEV NovaBay Pharmaceuticals, Inc. | JOther Series E Non-Voting Convertible Preferred Stockderivative | +134,375 | $0.00 | $0 | 134,375 | Oct 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.